Radiomic analysis of HTR-DCE MR sequences improves diagnostic performance compared to BI-RADS analysis of breast MR lesions.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 07 06 2020
accepted: 13 11 2020
revised: 27 09 2020
pubmed: 7 1 2021
medline: 24 6 2021
entrez: 6 1 2021
Statut: ppublish

Résumé

To assess the diagnostic performance of radiomic analysis using high temporal resolution (HTR)-dynamic contrast enhancement (DCE) MR sequences compared to BI-RADS analysis to distinguish benign from malignant breast lesions. We retrospectively analyzed data from consecutive women who underwent breast MRI including HTR-DCE MR sequencing for abnormal enhancing lesions and who had subsequent pathological analysis at our tertiary center. Semi-quantitative enhancement parameters and textural features were extracted. Temporal change across each phase of textural features in HTR-DCE MR sequences was calculated and called "kinetic textural parameters." Statistical analysis by LASSO logistic regression and cross validation was performed to build a model. The diagnostic performance of the radiomic model was compared to the results of BI-RADS MR score analysis. We included 117 women with a mean age of 54 years (28-88). Of the 174 lesions analyzed, 75 were benign and 99 malignant. Seven semi-quantitative enhancement parameters and 57 textural features were extracted. Regression analysis selected 15 significant variables in a radiomic model (called "malignant probability score") which displayed an AUC = 0.876 (sensitivity = 0.98, specificity = 0.52, accuracy = 0.78). The performance of the malignant probability score to distinguish benign from malignant breast lesions (AUC = 0.876, 95%CI 0.825-0.925) was significantly better than that of BI-RADS analysis (AUC = 0.831, 95%CI 0.769-0.892). The radiomic model significantly reduced false positives (42%) with the same number of missed cancers (n = 2). A radiomic model including kinetic textural features extracted from an HTR-DCE MR sequence improves diagnostic performance over BI-RADS analysis. • Radiomic analysis using HTR-DCE is of better diagnostic performance (AUC = 0.876) than conventional breast MRI reading with BI-RADS (AUC = 0.831) (p < 0.001). • A radiomic malignant probability score under 19.5% gives a negative predictive value of 100% while a malignant probability score over 81% gives a positive predictive value of 100%. • Kinetic textural features extracted from HTR-DCE-MRI have a major role to play in distinguishing benign from malignant breast lesions.

Identifiants

pubmed: 33404696
doi: 10.1007/s00330-020-07519-9
pii: 10.1007/s00330-020-07519-9
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4848-4859

Références

Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 1990 46(8):1296–1316
Mann RM, Cho N, Moy L (2019) Breast MRI: state of the art. Radiology. 292(3):520–536
pubmed: 31361209
Kuhl C (2007) The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology. 244(2):356–378
pubmed: 17641361
Mann RM, Mus RD, van Zelst J, Geppert C, Karssemeijer N, Platel B (2014) A novel approach to contrast-enhanced breast magnetic resonance imaging for screening: high-resolution ultrafast dynamic imaging. Invest Radiol 49(9):579–585
pubmed: 24691143
Milon A, Vande Perre S, Poujol J et al (2019) Abbreviated breast MRI combining FAST protocol and high temporal resolution (HTR) dynamic contrast enhanced (DCE) sequence. Eur J Radiol 117:199–208
pubmed: 31307648
Parekh VS, Jacobs MA (2017) Integrated radiomic framework for breast cancer and tumor biology using advanced machine learning and multiparametric MRI. NPJ Breast Cancer 3:43
pubmed: 29152563 pmcid: 5686135
Rizzo S, Botta F, Raimondi S et al (2018) Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months. Eur Radiol 28(11):4849–4859
pubmed: 29737390
Wu G, Woodruff HC, Sanduleanu S et al (2020) Preoperative CT-based radiomics combined with intraoperative frozen section is predictive of invasive adenocarcinoma in pulmonary nodules: a multicenter study. Eur Radiol 30(5):2680–2691
pubmed: 32006165 pmcid: 7160197
Thomassin-Naggara I, Soualhi N, Balvay D, Darai E, Cuenod C-A (2017) Quantifying tumor vascular heterogeneity with DCE-MRI in complex adnexal masses: a preliminary study. J Magn Reason Imaging. https://doi.org/10.1002/jmri.25707
Chang Y-C, Huang C-S, Liu Y-J, Chen J-H, Lu Y-S, Tseng W-YI (2004) Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI. Phys Med Biol 49(16):3593–3602
pubmed: 15446790
Ahmed A, Gibbs P, Pickles M, Turnbull L (2013) Texture analysis in assessment and prediction of chemotherapy response in breast cancer. J Magn Reason Imaging 38(1):89–101
Ashraf A, Gaonkar B, Mies C et al (2015) Breast DCE-MRI kinetic heterogeneity tumor markers: preliminary associations with neoadjuvant chemotherapy response. Transl Oncol 8(3):154–162
pubmed: 26055172
Bhooshan N, Giger ML, Jansen SA, Li H, Lan L, Newstead GM (2010) Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers. Radiology. 254(3):680–690
pubmed: 20123903
Kim J-H, Ko ES, Lim Y et al (2017) Breast cancer heterogeneity: MR imaging texture analysis and survival outcomes. Radiology. 282(3):665–675
pubmed: 27700229
Parikh J, Selmi M, Charles-Edwards G et al (2014) Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapy. Radiology. 272(1):100–112
pubmed: 24654970
Thibault G, Tudorica A, Afzal A et al (2017) DCE-MRI texture features for early prediction of breast cancer therapy response. Tomography 3(1):23–32
pubmed: 28691102 pmcid: 5500247
Wu J, Cao G, Sun X et al (2018) Intratumoral spatial heterogeneity at perfusion MR imaging predicts recurrence-free survival in locally advanced breast cancer treated with neoadjuvant chemotherapy. Radiology. 288(1):26–35
pubmed: 29714680
Wu J, Gong G, Cui Y, Li R (2016) Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy. J Magn Reason Imaging 44(5):1107–1115
Braman NM, Etesami M, Prasanna P et al (2017) Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res 19(1):57
pubmed: 28521821 pmcid: 5437672
Fan M, Li H, Wang S, Zheng B, Zhang J, Li L (2017) Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer. PLoS One 12(2):e0171683
pubmed: 28166261
Fan M, Cheng H, Zhang P et al (2018) DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers. J Magn Reason Imaging 48(1):237–247
Li H, Zhu Y, Burnside ES et al (2016) MR imaging radiomics signatures for predicting the risk of breast cancer recurrence as given by research versions of MammaPrint, Oncotype DX, and PAM50 gene assays. Radiology. 281(2):382–391
pubmed: 27144536
Truhn D, Schrading S, Haarburger C, Schneider H, Merhof D, Kuhl C (2019) Radiomic versus convolutional neural networks analysis for classification of contrast-enhancing lesions at multiparametric breast MRI. Radiology. 290(2):290–297
pubmed: 30422086
Fan M, Zhang P, Wang Y et al (2019) Radiomic analysis of imaging heterogeneity in tumours and the surrounding parenchyma based on unsupervised decomposition of DCE-MRI for predicting molecular subtypes of breast cancer. Eur Radiol 29(8):4456–4467
pubmed: 30617495
Lo Gullo R, Daimiel I, Rossi Saccarelli C et al (2020) Improved characterization of sub-centimeter enhancing breast masses on MRI with radiomics and machine learning in BRCA mutation carriers. Eur Radiol. https://doi.org/10.1007/s00330-020-06991-7
D’Amico NC, Grossi E, Valbusa G et al (2020) A machine learning approach for differentiating malignant from benign enhancing foci on breast MRI. Eur Radiol Exp 4(1):5
pubmed: 31993839 pmcid: 6987284
Saranathan M, Rettmann DW, Hargreaves BA, Clarke SE, Vasanawala SS (2012) DIfferential Subsampling with Cartesian Ordering (DISCO): a high spatio-temporal resolution Dixon imaging sequence for multiphasic contrast enhanced abdominal imaging. J Magn Reson Imaging 35(6):1484–1492
pubmed: 22334505 pmcid: 3354015
Morris EA, Comstock CE, Lee CH (2013) ACR BI-RADS Atlas - Breast Imaging Reporting and Data System Atlas. American College of Radiology, Reston, VA
DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 44(3):837–845
pubmed: 3203132
Thomassin-Naggara I, Bazot M, Daraï E, Callard P, Thomassin J, Cuenod CA (2008) Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. Radiology. 248(1):148–159
pubmed: 18458244
Thomassin-Naggara I, Daraï E, Cuenod CA, Rouzier R, Callard P, Bazot M (2008) Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging 28(1):111–120
pubmed: 18581400
Yushkevich PA, Piven J, Hazlett HC et al (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31(3):1116–1128
pubmed: 16545965
van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer Res 77(21):e104–e107
pubmed: 29092951 pmcid: 5672828
Zwanenburg A, Leger S, Vallières M, Löck S, Initiative for the IBS (2016) Image biomarker standardisation initiative. ArXiv161207003 Cs. [cited 2018 Mar 25]; Available from: http://arxiv.org/abs/1612.07003 . Accessed 25 March 2018 
Duron L, Balvay D, Vande Perre S et al (2019) Gray-level discretization impacts reproducible MRI radiomics texture features. PLoS One 14(3):e0213459
pubmed: 30845221
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. [Internet]. 2013. Available from:  http://www.R-project.org/ . Accessed 25 Feb 2019
Tibshirani R (1996) Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B Methodol 58(1):267–288
Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14(12):749–762
Liang C, Cheng Z, Huang Y et al (2018) An MRI-based radiomics classifier for preoperative prediction of Ki-67 status in breast cancer. Acad Radiol 25(9):1111–1117
pubmed: 29428211
Harvey SC, Di Carlo PA, Lee B, Obadina E, Sippo D, Mullen L (2016) An abbreviated protocol for high-risk screening breast MRI saves time and resources. J Am Coll Radiol 13(11S):R74–R80
Kuhl CK (2018) Abbreviated breast MRI for screening women with dense breast: the EA1141 trial. Br J Radiol 91(1090):20170441
pubmed: 28749202
Cuenod CA, Balvay D (2013) Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI. Diagn Interv Imaging 94(12):1187–1204
pubmed: 24211260
Pradel C, Siauve N, Bruneteau G et al (2003) Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast media. Magn Reson Imaging 21(8):845–851
pubmed: 14599534
Folkman J. Tumor angiogenesis. In: Klein G, Weinhouse S, editors. Advances in cancer research. Academic Press; 1985 [cited 2018 Jun 6]. p. 175–203. Available from: http://www.sciencedirect.com/science/article/pii/S0065230X0860946X . Accessed 06 June 2018
McDonald DM, Choyke PL (2003) Imaging of angiogenesis: from microscope to clinic. Nat Med 9(6):713–725
pubmed: 12778170
Fukumura D, Jain RK (2008) Imaging angiogenesis and the microenvironment. APMIS 116(7–8):695–715
pubmed: 18834413 pmcid: 2859845
Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3(6):401–410
pubmed: 12778130
Reig B, Heacock L, Geras KJ, Moy L (2019) Machine learning in breast MRI. J Magn Reason Imaging. https://doi.org/10.1002/jmri.26852
Agner SC, Soman S, Libfeld E et al (2011) Textural kinetics: a novel dynamic contrast-enhanced (DCE)-MRI feature for breast lesion classification. J Digit Imaging 24(3):446–463
pubmed: 20508965
Milenković J, Dalmış MU, Žgajnar J, Platel B (2017) Textural analysis of early-phase spatiotemporal changes in contrast enhancement of breast lesions imaged with an ultrafast DCE-MRI protocol. Med Phys 44(9):4652–4664
pubmed: 28622412
Zhou X, Gao F, Duan S et al (2020) Radiomic features of Pk-DCE MRI parameters based on the extensive Tofts model in application of breast cancer. Phys Eng Sci Med 43(2):517–524
Valdora F, Houssami N, Rossi F, Calabrese M, Tagliafico AS (2018) Rapid review: radiomics and breast cancer. Breast Cancer Res Treat 169(2):217–229
pubmed: 29396665
Whitney HM, Li H, Ji Y, Liu P, Giger ML (2020) Harmonization of radiomic features of breast lesions across international DCE-MRI datasets. J Med Imaging (Bellingham) 7(1):012707
Rotili A, Trimboli RM, Penco S et al (2020) Double reading of diffusion-weighted magnetic resonance imaging for breast cancer detection. Breast Cancer Res Treat 180(1):111–120
pubmed: 31938940

Auteurs

Saskia Vande Perre (SV)

Tenon Hospital, APHP, Sorbonne Université, 75020, Paris, France.
PARCC, INSERM, Université de Paris, F-75015, Paris, France.

Loïc Duron (L)

PARCC, INSERM, Université de Paris, F-75015, Paris, France.

Audrey Milon (A)

Tenon Hospital, APHP, Sorbonne Université, 75020, Paris, France.

Asma Bekhouche (A)

Tenon Hospital, APHP, Sorbonne Université, 75020, Paris, France.

Daniel Balvay (D)

PARCC, INSERM, Université de Paris, F-75015, Paris, France.

Francois H Cornelis (FH)

Tenon Hospital, APHP, Sorbonne Université, 75020, Paris, France.
ISCD, Sorbonne Université, 75005, Paris, France.

Laure Fournier (L)

PARCC, INSERM, Université de Paris, F-75015, Paris, France.
HEGP, APHP Université de Paris, Univ Paris 06, IUC, 75015, Paris, France.

Isabelle Thomassin-Naggara (I)

Tenon Hospital, APHP, Sorbonne Université, 75020, Paris, France. isabelle.thomassin@tnn.aphp.fr.
ISCD, Sorbonne Université, 75005, Paris, France. isabelle.thomassin@tnn.aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH